These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6154406)

  • 1. A comparison of the effects of intravenous serotonin and dextran on the levels of factor XII, prekallikrein and plasminogen in rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):314-20. PubMed ID: 6154406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextran-induced lowering of prekallikrein proactivator and prekallikrein in rat plasma.
    Briseid G; Briseid K; Toverud EL; Kristoffersen J
    Acta Pharmacol Toxicol (Copenh); 1978 Feb; 42(2):93-102. PubMed ID: 580160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prekallikrein activator and kallikrein in acetone- and kaolin-activated rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):174-80. PubMed ID: 506739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO; Briseid G
    Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma.
    Briseid K; Johansen R; Rustenberg L
    Adv Exp Med Biol; 1979; 120B():101-12. PubMed ID: 517228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of serotonin antagonists on the dextran-induced anaphylactoid reaction in the rat.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1981 May; 48(5):438-43. PubMed ID: 6175173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous radiographic contrast media on the blood pressure and on factors of the contact activation system in the rat.
    Hoem NO; Briseid G; Ekelund S; Salvesen S
    Acta Pharmacol Toxicol (Copenh); 1986 Sep; 59(3):189-94. PubMed ID: 2432754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran-induced lowering of plasminogen proactivator and functionally active high molecular weight kininogen in the rat.
    Berstad J; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):342-9. PubMed ID: 6180597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine esterase in cerebrospinal fluid and pro-arginine esterase in plasma from patients with migraine.
    Briseid K; Falkum A; Qvigstad EK; Stien R
    Acta Neurol Scand; 1976 Oct; 54(4):301-11. PubMed ID: 973552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein.
    Kluft C
    J Lab Clin Med; 1978 Jan; 91(1):83-95. PubMed ID: 618993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of factor XII in plasma from rats pretreated with tranexamic acid. Inhibition of a plasmin-induced loss of the functional activity of high molecular weight kininogen.
    Briseid K; Ryssdal AB
    Acta Pharmacol Toxicol (Copenh); 1980 Sep; 47(3):161-70. PubMed ID: 6449829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of plasma kallikrein and a kallikrein-like plasminogen activator generated by acetone in rat plasma.
    Johansen HT; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1983 May; 52(5):371-80. PubMed ID: 6554030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextran-induced anaphylactoid reaction in man: altered reactivity of high molecular weight kininogen.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):119-26. PubMed ID: 6159774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma: significance of monoamine-depleting agents.
    Briseid K; Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):169-73. PubMed ID: 506738
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase.
    Claeson G; Friberger P; Knös M; Eriksson E
    Haemostasis; 1978; 7(2-3):76-8. PubMed ID: 26629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assay for prekallikrein activator (PKA).
    Lundblad JL
    Dev Biol Stand; 1979; 44():107-14. PubMed ID: 317466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.
    Colman RW; Mattler L; Sherry S
    J Clin Invest; 1969 Jan; 48(1):23-32. PubMed ID: 4237065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
    Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
    J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.